Literature DB >> 20628269

Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor.

Xun Jin1, Samuel Beck, Young-Woo Sohn, Jun-Kyum Kim, Sung-Hak Kim, Jinlong Yin, Xumin Pian, Sung-Chan Kim, Yun-Jaie Choi, Hyunggee Kim.   

Abstract

Although human telomerase catalytic subunit (TERT) has several cellular functions including telomere homeostasis, genomic stability, cell proliferation, and tumorigenesis, the molecular mechanism underlying anti-apoptosis regulated by TERT remains to be elucidated. Here, we show that ectopic expression of TERT in spontaneously immortalized human fetal fibroblast (HFFS) cells, which are a telomerase- and p53-positive, leads to increases of cell proliferation and transformation, as well as a resistance to DNA damage response and inactivation of p53 function. We found that TERT and a mutant TERT (no telomerase activity) induce expression of basic fibroblast growth factor (bFGF), and ectopic expression of bFGF also allows cells to be resistant to DNA-damaging response and to suppress activation of p53 function under DNA-damaging induction. Furthermore, loss of TERT or bFGF markedly increases a p53 activity and DNA-damage sensitivity in HFFS, HeLa and U87MG cells. Therefore, our findings indicate that a novel TERT-bFGF axis accelerates the inactivation of p53 and consequent increase of resistance to DNA-damage response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20628269      PMCID: PMC2928930          DOI: 10.3858/emm.2010.42.8.058

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  28 in total

1.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Expression of human telomerase (hTERT) does not prevent stress-induced senescence in normal human fibroblasts but protects the cells from stress-induced apoptosis and necrosis.

Authors:  Vera Gorbunova; Andrei Seluanov; Olivia M Pereira-Smith
Journal:  J Biol Chem       Date:  2002-07-24       Impact factor: 5.157

Review 3.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

4.  Fatal liaisons of p53 with Bax and Bak.

Authors:  Jean-Luc Perfettini; Romano T Kroemer; Guido Kroemer
Journal:  Nat Cell Biol       Date:  2004-05       Impact factor: 28.824

5.  Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis.

Authors:  Rosalie M Luiten; Jérome Péne; Hans Yssel; Hergen Spits
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

Review 6.  Clinical utility of telomerase in cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

7.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.

Authors:  Laura L Smith; Hilary A Coller; James M Roberts
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

8.  The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression.

Authors:  Rui Wang; Fang Lin; Xi Wang; Ping Gao; Ke Dong; San-Hua Wei; Shi-Yin Cheng; Hui-Zhong Zhang
Journal:  Cancer Biol Ther       Date:  2007-05-26       Impact factor: 4.742

9.  Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.

Authors:  Ryota Tomoda; Masashi Seto; Hideaki Tsumuki; Koji Iida; Takashi Yamazaki; Jun Sonoda; Akihiko Matsumine; Atsumasa Uchida
Journal:  Cancer       Date:  2002-09-01       Impact factor: 6.860

10.  Telomerase activity and genetic alterations in primary breast carcinomas.

Authors:  Anna Papadopoulou; Theoni Trangas; Manuel R Teixeira; Sverre Heim; Euthimios Dimitriadis; Haroula Tsarouha; Johan A Andersen; Evangelos Evangelou; Panayiotis Ioannidis; Niki J Agnantis; Nikos Pandis
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

View more
  19 in total

1.  Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.

Authors:  Enrica Rampazzo; Laura Bonaldi; Livio Trentin; Carlo Visco; Sonia Keppel; Silvia Giunco; Federica Frezzato; Monica Facco; Elisabetta Novella; Ilaria Giaretta; Paola Del Bianco; Gianpietro Semenzato; Anita De Rossi
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Differences in telomerase activity between colon and rectal cancer.

Authors:  Georgios D Ayiomamitis; George Notas; Apostolos Zaravinos; Adamantia Zizi-Sermpetzoglou; Maria Georgiadou; Ourania Sfakianaki; Elias Kouroumallis
Journal:  Can J Surg       Date:  2014-06       Impact factor: 2.089

Review 3.  Telomeres, telomerase and colorectal cancer.

Authors:  Roberta Bertorelle; Enrica Rampazzo; Salvatore Pucciarelli; Donato Nitti; Anita De Rossi
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Telomerase activity-independent function of TERT allows glioma cells to attain cancer stem cell characteristics by inducing EGFR expression.

Authors:  Samuel Beck; Xun Jin; Young-Woo Sohn; Jun-Kyum Kim; Sung-Hak Kim; Jinlong Yin; Xumin Pian; Sung-Chan Kim; Do-Hyun Nam; Yun-Jaie Choi; Hyunggee Kim
Journal:  Mol Cells       Date:  2010-12-24       Impact factor: 5.034

5.  The Relationship between Telomerase Activity and Clinicopathological Parameters in Colorectal Cancer: A Meta-Analysis.

Authors:  Xue-Cheng Xie; Lian-Ying Ge; Hao Lai; Hai Qiu; Fan Tang; Yu-Zhou Qin
Journal:  Balkan Med J       Date:  2016-01-01       Impact factor: 2.021

6.  A Comparative Assessment of Replication Stress Markers in the Context of Telomerase.

Authors:  Sabine Meessen; Gregoire Najjar; Anca Azoitei; Sebastian Iben; Christian Bolenz; Cagatay Günes
Journal:  Cancers (Basel)       Date:  2022-04-28       Impact factor: 6.575

7.  Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-analysis.

Authors:  Mu-Han Lü; Jia-Qi Deng; Ya-Ling Cao; Dian-Chun Fang; Yao Zhang; Shi-Ming Yang
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

8.  Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal Carcinogenesis.

Authors:  Karoline Horisberger; Thomas Ried; Timo Gaiser; Daniela Hirsch; Darawalee Wangsa; Yuelin J Zhu; Yue Hu; Daniel C Edelman; Paul S Meltzer; Kerstin Heselmeyer-Haddad; Claudia Ott; Peter Kienle; Christian Galata
Journal:  Clin Cancer Res       Date:  2018-07-02       Impact factor: 12.531

9.  Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.

Authors:  R Bertorelle; M Briarava; E Rampazzo; L Biasini; M Agostini; I Maretto; S Lonardi; M L Friso; C Mescoli; V Zagonel; D Nitti; A De Rossi; S Pucciarelli
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

10.  HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes.

Authors:  Jonathan Miller; Aleksandra Dakic; Renxiang Chen; Nancy Palechor-Ceron; Yuhai Dai; Bhaskar Kallakury; Richard Schlegel; Xuefeng Liu
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.